Expert Stock Recommendations for March 25, 2026
Mehul Kothari, DVP of Technical Research at Anand Rathi Shares and Stock Brokers, has identified three promising stocks for investors to consider on March 25, 2026. His analysis focuses on technical indicators and chart patterns, providing specific entry points, stop-loss levels, and target prices for each stock.
Aurobindo Pharma: Breakout with Strong Momentum
Buy Range: ₹1,280 to ₹1,260 | Stop Loss: ₹1,235 | Target: ₹1,390
Aurobindo Pharma has exhibited a decisive breakout following an extended period of consolidation, signaling a potential resumption of its upward trend. The stock had been trading within a narrow range, forming a solid base that preceded this significant upward movement.
From a technical perspective, the setup appears highly constructive with multiple indicators aligning favorably for bullish investors. The Directional Movement Index (DMI) reflects a positive bias, indicating strengthening directional momentum. Simultaneously, the Relative Strength Index (RSI) has climbed above the 60 mark, demonstrating robust buying interest and improving trend strength.
Furthermore, the Moving Average Convergence Divergence (MACD) has executed a bullish crossover above the zero line, confirming a distinct shift in momentum toward the upside. This convergence of breakout signals and momentum indicators strongly suggests a continuation of the upward trajectory, provided the stock maintains its position above the breakout zone.
Infosys: Bullish Divergence Signaling Potential Reversal
Buy Range: ₹1,270 to ₹1,240 | Stop Loss: ₹1,175 | Target: ₹1,375
Infosys is displaying early indications of a potential trend reversal as momentum indicators begin to diverge from the prevailing price action. While the stock has been forming lower lows, the RSI has been creating higher lows, revealing a clear bullish divergence that suggests selling pressure is gradually diminishing.
Adding to this positive signal, the MACD has generated a bullish crossover, reflecting improving momentum and a possible shift in short-term trend direction. This combination of RSI divergence and MACD confirmation points toward emerging accumulation at lower price levels. The technical setup indicates a high probability of a relief rally or short-term recovery as momentum stabilizes and buying interest increases.
Larsen & Toubro: Oversold Bounce with Positive Divergence
Buy Range: ₹3,400 to ₹3,350 | Stop Loss: ₹3,250 | Target: ₹3,600
Larsen & Toubro appears to be approaching exhaustion in its recent downtrend, with momentum indicators signaling a potential technical bounce. Despite the extended decline in price, the RSI is not establishing fresh lower lows, indicating positive divergence and a gradual reduction in selling momentum.
Concurrently, the MACD is positioned within an oversold zone, which typically reflects trend exhaustion and increases the likelihood of a reversal or technical pullback. The alignment of these indicators suggests that the stock may experience a short-term recovery if buying interest emerges near current price levels, presenting a potential opportunity for investors.
Disclaimer: The recommendations and views expressed by market experts are their own and do not represent the opinions of any publication or financial institution. Investors should conduct their own research and consult with financial advisors before making investment decisions.
